Prometheus Biosciences, Inc. (RXDX) Financials

NASDAQ Currency in USD Disclaimer

$199.92

north_east NA Past Year
Day's range
$199.92
Day's range
$199.96
$50M$50M$0$0-$50M-$50M-$100M-$100M-$150M-$150MEarning201520152016201620172017202020202021202120222022202320230%0%-10000%-10000%-20000%-20000%-30000%-30000%-40000%-40000%Profit Margin
Profit Margin
Revenue
Earnings

RXDX Income statement / Annual

Last year (2023), Prometheus Biosciences, Inc.'s total revenue was $6.81 M, an increase of 117.61% from the previous year. In 2023, Prometheus Biosciences, Inc.'s net income was -$141.75 M. See Prometheus Biosciences, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $6.81 M $3.13 M $1.23 M $1.12 M $0.00 $0.00 $150,000.00
Cost of Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit $6.81 M $3.13 M $1.23 M $1.12 M $0.00 $0.00 $150,000.00
Gross Profit Ratio 1 1 1 1 0 0 1
Research and Development Expenses $112.85 M $62.43 M $19.15 M $10.96 M $76.93 M $73.51 M $30.51 M
General & Administrative Expenses $39.74 M $28.51 M $11.09 M $6.13 M $23.76 M $17.07 M $9.49 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $39.74 M $28.51 M $11.09 M $6.13 M $23.76 M $17.07 M $9.49 M
Other Expenses $4.03 M -$2.39 M -$15,000.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $152.59 M $90.93 M $30.24 M $17.09 M $100.68 M $90.58 M $40.00 M
Cost And Expenses $152.59 M $90.93 M $30.24 M $17.09 M $100.68 M $90.58 M $40.00 M
Interest Income $4.03 M $108,000.00 $13,000.00 $9,000.00 $0.00 $0.00 $0.00
Interest Expense $0.00 $861,000.00 $2.13 M $770,000.00 $3.21 M $2.59 M $0.00
Depreciation & Amortization $629,000.00 $258,000.00 $107,000.00 $44,000.00 $3.48 M $2.04 M $527,675.00
EBITDA -$145.78 M -$87.80 M -$28.90 M -$15.92 M -$96.95 M -$87.83 M -$39.45 M
EBITDA Ratio -21.41 -28.06 -23.52 -14.24 0 0 -263
Operating Income Ratio -21.41 -28.06 -23.6 -14.28 0 0 -265.66
Total Other Income/Expenses Net $4.03 M -$2.39 M -$2.13 M -$761,000.00 -$2.96 M -$1.88 M -$128,421.00
Income Before Tax -$141.75 M -$90.20 M -$31.14 M -$16.73 M -$103.64 M -$92.46 M -$39.98 M
Income Before Tax Ratio -20.82 -28.83 -25.34 -14.96 0 0 -266.52
Income Tax Expense -$629,000.00 -$258,000.00 $8.11 M $13.76 M $259,000.00 $715,000.00 $12,330.00
Net Income -$141.75 M -$89.94 M -$39.25 M -$30.49 M -$103.64 M -$92.46 M -$39.99 M
Net Income Ratio -20.82 -28.74 -31.94 -27.27 0 0 -266.6
EPS -3.49 -2.87 -1.13 -1.13 -2.69 -3.44 -2.18
EPS Diluted -3.49 -2.87 -1.13 -1.13 -2.69 -3.44 -2.18
Weighted Average Shares Out $40.62 M $31.33 M $34.61 M $26.98 M $38.48 M $26.85 M $18.33 M
Weighted Average Shares Out Diluted $40.62 M $31.33 M $34.61 M $26.98 M $38.48 M $26.85 M $18.33 M
Link